The Edmond J. Safra Center for Bioinformatics at Tel Aviv University (TAU) is a leading interdisciplinary research hub dedicated to advancing computational and systems-level approaches to biology and medicine. The Center brings together experts in bioinformatics, computational biology, artificial intelligence, data science, and biomedical engineering to uncover fundamental biological mechanisms and develop innovative solutions to complex challenges in human health.
University of California San Francisco
About UCSF
Partnership Evolution
Symposium
QBI–TAU Second Symposium on Computational Biology and Drug Discovery
QBI and TAU host their second joint symposium in San Francisco to further advance collaboration in computational biology and drug discovery and strengthen ongoing research connections to support the continued growth of this partnership.
May 16, 2023- May 17, 2023
Funding Opportunity
QBI and TAU Launch Joint Seed Grant Program
Through a collaborative funding initiative, QBI and TAU awarded $300K in joint seed grants to foster new partnerships in computational biology and drug discovery. The program connected researchers across institutions, supporting innovative projects designed to accelerate translational research and therapeutic development.
Jan 21, 2021
Symposium
QBI-TAU Symposium in Computational Biology and Drug Discovery
QBI and TAU launched their collaboration with an inaugural symposium in Israel in computational biology and drug discovery, bringing together interdisciplinary researchers to explore data-driven approaches to therapeutic development.
Dec 04, 2019- Dec 05, 2019
Stories & Highlights
May 18, 2023
Reigniting a Collaboration: QBI and TAU Advance Computational Biology and Drug Discovery
QBI welcomed colleagues from Tel Aviv University for the second QBI–TAU Symposium on Computational Biology and Drug Discovery, a two-day meeting that marked a renewed chapter in a rapidly growing international partnership.
Dec 05, 2019
The Inaugural QBI|UCSF-TAU Symposium
QBI and TAU came together in Israel to launch an inaugural joint-symposium with the goal of forming collaborations, as well as making new connections and synergies between scientists at both institutions to help facilitate drug discovery through the use of computational approaches.